LL3 Stock Overview
Operates as a precision health company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Pangenomic Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.20 |
| 52 Week High | CA$1.11 |
| 52 Week Low | CA$0.083 |
| Beta | -1.37 |
| 11 Month Change | 12.96% |
| 3 Month Change | 54.23% |
| 1 Year Change | -78.89% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -97.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| LL3 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 23.4% | -1.3% | -0.4% |
| 1Y | -78.9% | -33.1% | 7.1% |
Return vs Industry: LL3 underperformed the German Healthcare Services industry which returned -32.3% over the past year.
Return vs Market: LL3 underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| LL3 volatility | |
|---|---|
| LL3 Average Weekly Movement | 65.8% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LL3's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: LL3's weekly volatility has increased from 57% to 66% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Maryam Marissen | www.pangenomic.com |
Pangenomic Health Inc. operates as a precision health company. It develops the Nara App, a mental health app provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; Mindleap, a telehealth platform curates a variety of tools and resources to help individuals understand and improve their inner wellness; and MUJN, a clinical decision support platform that offers health practitioners with access to the consumer's mobile app data and their diagnostic reports. The company was formerly known as Zetta Capital Corp. and changed its name to Pangenomic Health Inc. in December 2021.
Pangenomic Health Inc. Fundamentals Summary
| LL3 fundamental statistics | |
|---|---|
| Market cap | €3.04m |
| Earnings (TTM) | -€2.52m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.4x
P/E RatioIs LL3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LL3 income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$356.03k |
| Gross Profit | -CA$356.03k |
| Other Expenses | CA$3.36m |
| Earnings | -CA$3.71m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.58 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did LL3 perform over the long term?
See historical performance and comparison